A multicentre, prospective, non-interventional study evaluating the safety of dapagliflozin in patients with type 2 diabetes in routine clinical practice in China (DONATE)

BACKGROUND: There are few large-scale studies evaluating the safety of the sodium-glucose cotransporter-2 inhibitor, dapagliflozin, in Chinese patients with type 2 diabetes. DONATE, a multicentre, single-arm, prospective, non-interventional study, is the first real-world study evaluating the safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Lixin, Wang, Jing, Li, Li, Yuan, Lin, Chen, Sheng, Wang, Hui, Li, Tonghuan, Qi, Lin, Yang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268430/
https://www.ncbi.nlm.nih.gov/pubmed/37316847
http://dx.doi.org/10.1186/s12916-023-02906-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268430/
https://www.ncbi.nlm.nih.gov/pubmed/37316847
http://dx.doi.org/10.1186/s12916-023-02906-7

Ejemplares similares